Comparison of the MoCA and BEARNI tests for detection of cognitive impairment in in-patients with alcohol use disorders

Autor: Régis Alarcon, Stéphanie Pelletier, Valérie Ewert, Margot Forest, Pascal Perney, Bertrand Nalpas
Přispěvatelé: Hôpital Universitaire de Réadaptation, de Rééducation et d'Addictologie du CHU de Nîmes [Grau-du-Roi] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université de Montpellier (UM)
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
medicine.medical_specialty
medicine.medical_treatment
Population
030508 substance abuse
Alcohol
Alcohol use disorder
Neuropsychological Tests
Toxicology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Internal medicine
medicine
Humans
Cognitive Dysfunction
Pharmacology (medical)
BEARNI
education
Cognitive deficit
Aged
MoCA
Pharmacology
education.field_of_study
Rehabilitation
business.industry
Neuropsychology
Montreal Cognitive Assessment
Cognition
Middle Aged
medicine.disease
3. Good health
Psychiatry and Mental health
Alcoholism
chemistry
[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health
Screening
Female
Substance Abuse Treatment Centers
medicine.symptom
0305 other medical science
business
030217 neurology & neurosurgery
Zdroj: Drug and Alcohol Dependence
Drug and Alcohol Dependence, Elsevier, 2018, 187, pp.249-253. ⟨10.1016/j.drugalcdep.2018.02.026⟩
ISSN: 0376-8716
1879-0046
Popis: Introduction Screening of cognitive impairment is a major challenge in alcoholics seeking treatment, since cognitive dysfunction may impair the overall efficacy of rehabilitation programs and consequently increase relapse rate. We compared the performance of two screening tools: the MoCA (Montreal Cognitive Assessment), which is widely used in patients with neurological diseases and already used in patients with alcohol use disorder (AUD), and the BEARNI (Brief Evaluation of Alcohol-Related Neuropsychological Impairments), a recent test specifically developed for the alcoholic population. Methods We compared the sensitivity and specificity of the MoCA and the BEARNI in a sample of AUD patients with and without cognitive impairment assessed by a battery of neuropsychological tests. Results Ninety patients were included. There were 67 men and 23 women aged 48.9 ± 9.6 years. According to the neuropsychological tests, 51.1% of patients had no cognitive impairment, while it was mild or moderate to severe in 31.1 and 17.8%, respectively. The BEARNI sensitivity was extremely high (1.0), since all patients with cognitive impairment were identified, but its specificity was very low (0.04). The MoCA had a lower sensitivity (0.79) than the BEARNI, but its specificity was significantly better (0.65). A detailed analysis of the BEARNI scores showed a discrepancy between the qualitative and quantitative interpretation of the test which could, at least in part, explain its low specificity. Conclusion Both the MoCA and the BEARNI are screening tools which identified alcoholic patients with cognitive impairment. However, in routine use, the MoCA appeared to be more appropriate given the low specificity of the BEARNI.
Databáze: OpenAIRE
Externí odkaz: